Maximus MMS Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Outside the U.S. | $568.88M-0.8% | $573.32M-4.4% | $599.89M-5.7% | $635.89M-1.8% | $647.76M-2.9% | |
| U.S. Services | $1.7B-1.5% | $1.73B-2.1% | $1.76B-1.9% | $1.8B-1.8% | $1.83B-2.3% | |
| Gross Profit by Business | ||||||
| Outside the U.S. | $89.12M-8.9% | $97.8M-12.4% | $111.7M-4.9% | $117.4M+1.9% | $115.18M+0.8% | |
| U.S. Services | $389.11M-2.8% | $400.37M-2.6% | $410.98M-2.8% | $423M-3.4% | $438.08M-4.0% | |
| Revenue by Product | ||||||
| Clinical Services | $2.18B+1.2% | $2.15B+2.5% | $2.1B+3.7% | $2.03B+2.8% | $1.97B+1.9% | |
| Employment & Other | $292.4M-6.1% | $311.38M-12.2% | $354.84M-10.7% | $397.41M-7.0% | $427.55M-8.0% | |
| Program Operations | $2.55B-1.8% | $2.6B-1.9% | $2.65B-0.3% | $2.66B+0.8% | $2.64B+1.0% | |
| Technology Solutions | $292.12M-5.7% | $309.93M-4.6% | $324.73M-6.2% | $346.07M-3.6% | $359.11M-3.4% | |
| Concentration Risk, Percentage by Product | ||||||
| Clinical Services | 122.5%+3.6pp | 118.9%+5.3pp | 113.6%+0.9pp | 112.7%+3.1pp | 109.6%+2.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Maximus break its business down?
- Maximus (MMS) reports revenue by business across 2 parts — Outside the U.S. and U.S. Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Maximus's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Maximus's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.